Special Issue "Bioactive Molecules from Plants: Discovery and Pharmaceutical Applications, 3rd Edition"
Deadline for manuscript submissions: closed (20 September 2023) | Viewed by 1541
Interests: bioactive compounds; cell signaling; drug delivery; drug discovery; enzymology; high-throughput screening; metalloproteases; molecular pharmacology; nanoparticles; neuropeptides; neurodegenerative diseases; parkinson's disease; protein-protein interaction inhibitors; protein engineering; protein structure; protease inhibitors; protein folding and aggregation; substrate specificity; X-ray crystallography
Special Issues, Collections and Topics in MDPI journals
Special Issue in Pharmaceutics: Bioactive Molecules from Plants: Discovery and Pharmaceutical Applications (Volume II)
Special Issue in Pharmaceutics: Novel Therapeutic Approaches for Neurodegenerative Diseases Treatment
Special Issue in Pharmaceutics: Novel Therapeutic Approaches for Neurodegenerative Diseases Treatment, 2nd Edition
Plants have historically proven their value as a source of bioactive molecules with pharmaceutical potential, and due to increasing demand for chemical diversity in pharmaceutical screening programs, the identification of novel therapeutic drugs from natural sources represents an interesting approach. Indeed, plants are extremely rich sources of bioactive molecules that are useful for a multitude of applications in the fields of biomedicine, cosmetics, and the food industry.
The focus of this Special Issue is the identification, extraction, purification, characterization and formulation of novel bioactive molecules derived from plants. The topics include, but are not limited to, bioactive compounds as supplements for functional foods and cosmetics, novel molecules with antioxidant properties, bioactive compounds targeting cell survival and cell signaling pathways, novel protein and non-protein protease inhibitors from plants, bioactive molecules with anti-bacterial, anti-fungal, or antiviral properties, and compounds with immunomodulatory effects.
Dr. Javier Garcia-Pardo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antimicrobial activity
- antiviral agent
- bioactive molecules
- cell signaling
- drug discovery
- functional foods
- high-throughput screening
- medicinal chemistry
- medicinal plants
- protease inhibitor
- drug delivery